ReviewBMC infectious diseases2025
Disseminated Talaromyces marneffei infection in a patient with Ankylosing Spondylitis: a case report and review of the literature.
Review in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnkylosing Spondylitis (AS) is a prevalent autoimmune disorder that necessitates the prolonged use of corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs), and disease-modifying antirheumatic drugs (DMARDs). Immunosuppressive medications are now commonly incorporated into treatment plans; however, this may increase patients' risk of severe infections. Infections caused by Talaromyces marneffei (TM) are rarely seen in patients with AS, yet if left untreated, they could result in severe morbidity and even death. CASE REPORT: This report presents a comprehensive case study of a 44-year-old Human Immunodeficiency Virus (HIV)-negative male with Ankylosing Spondylitis (AS) complicated by diabetes mellitus, who developed both soft tissue and pulmonary infections. Initial diagnosis suggested a bacterial etiology; however, clinical response to broad-spectrum antibiotics was suboptimal. Subsequent diagnostic procedures, including biopsy and culture of axillary lymph nodes and pulmonary tissue, coupled with Metagenomic Next-Generation Sequencing (mNGS), confirmed the diagnosis of disseminated TM infection. The patient achieved favorable outcomes following targeted antifungal therapy.
conclusionPatients with compromised immune function due to chronic immunosuppressive treatments require vigilant monitoring for uncommon opportunistic pathogens, particularly fungal infections. Advanced diagnostic techniques for early identification of pathogens, prompt and accurate prescription of antimicrobial agents, tailored dosing schedules, and stringent monitoring for potential complications are crucial for optimizing patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.